Hot Features
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, ... Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.145 | -5.27272727273 | 2.75 | 2.905 | 2.49 | 946904 | 2.68529961 | CS |
| 4 | -0.295 | -10.1724137931 | 2.9 | 2.98 | 2.35 | 869600 | 2.61439469 | CS |
| 12 | 0.985 | 60.8024691358 | 1.62 | 2.98 | 1.41 | 1278358 | 2.27180397 | CS |
| 26 | 0.735 | 39.3048128342 | 1.87 | 2.98 | 0.9583 | 1649051 | 1.77329514 | CS |
| 52 | 0.165 | 6.76229508197 | 2.44 | 3.87 | 0.9583 | 1300205 | 2.01390435 | CS |
| 156 | 0.015 | 0.579150579151 | 2.59 | 6.08 | 0.9583 | 923406 | 2.53683466 | CS |
| 260 | -18.835 | -87.8498134328 | 21.44 | 42.01 | 0.9583 | 864622 | 6.51266596 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.